D. Lavanchy, Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention, Journal of Clinical Virology, vol.34, issue.1, pp.1-3, 2005.
DOI : 10.1016/S1386-6532(05)00384-7

W. Maddrey, Hepatitis B: An important public health issue, Journal of Medical Virology, vol.38, issue.3, pp.362-366, 2000.
DOI : 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I

M. Funk, D. Rosenberg, and A. Lok, World-wide epidemiology of HBeAgnegative chronic hepatitis B and associated precore and core promoter variants

S. Hadziyannis and G. Papatheodoridis, Hepatitis B e Antigen-Negative Chronic Hepatitis B: Natural History and Treatment, Seminars in Liver Disease, vol.26, issue.2, pp.130-141, 2006.
DOI : 10.1055/s-2006-939751

W. Carman, M. Jacyna, S. Hadziyannis, P. Karayiannis, M. Mcgarvey et al., MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION, The Lancet, vol.334, issue.8663, pp.588-591, 1989.
DOI : 10.1016/S0140-6736(89)90713-7

A. Laras, J. Koskinas, K. Avgidis, and S. Hadziyannis, Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients, Journal of Viral Hepatitis, vol.5, issue.4, pp.241-248, 1998.
DOI : 10.1016/S0140-6736(89)90713-7

A. Lok, U. Akarca, and S. Greene, Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal., Proceedings of the National Academy of Sciences, vol.91, issue.9, pp.4077-4081, 1994.
DOI : 10.1073/pnas.91.9.4077

H. Chan, M. Hussain, A. Lok, A. Knoll, A. Rohrhofer et al., Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany, Hepatology J Med Virol, vol.2959, issue.10, pp.976-98414, 1999.

S. Hadziyannis and D. Vassilopoulos, Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection, Antiviral Research, vol.52, issue.2, pp.91-98, 2001.
DOI : 10.1016/S0166-3542(01)00173-5

W. Caselmann, Differential antigen-processing pathways of the hepatitis B virus e and core proteins, Gastroenterology, vol.116, pp.650-657, 1999.

B. Rehermann, Immune Responses in Hepatitis B Virus Infection, Seminars in Liver Disease, vol.23, issue.1, pp.21-38, 2003.
DOI : 10.1055/s-2003-37586

D. Milich and T. Liang, Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection, Hepatology, vol.348, issue.5, pp.1075-1086, 2003.
DOI : 10.1053/jhep.2003.50453

L. Frelin, T. Wahlstrom, A. Tucker, J. Jones, J. Hughes et al., A mechanism to explain the selection of the HBeAg-negative mutant during chronic HBV infection Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B, J Virol Hepatology, vol.1634, pp.617-624, 2001.

S. Hadziyannis, Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients, Expert Opinion on Investigational Drugs, vol.34, issue.6, pp.777-786, 2007.
DOI : 10.1016/S0168-8278(06)80495-2

C. Chu, M. Hussain, and A. Lok, Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection, Hepatology, vol.34, issue.6, pp.1408-1415, 2002.
DOI : 10.1002/hep.1840360617

F. Callea, Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe, Gastroenterology, vol.90, pp.1268-1273, 1986.

B. Rehermann and M. Nascimbeni, Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews Immunology, vol.24, issue.3, pp.215-229, 2005.
DOI : 10.1172/JCI200318509

G. Fattovich, Natural History and Prognosis of Hepatitis B, Seminars in Liver Disease, vol.23, issue.1, pp.47-58, 2003.
DOI : 10.1055/s-2003-37590

A. Perelson, MODELLING VIRAL AND IMMUNE SYSTEM DYNAMICS, Nature Reviews Immunology, vol.284, issue.1, pp.28-36, 2002.
DOI : 10.1006/bulm.1997.0035

A. Perelson, E. Herrmann, F. Micol, and S. Zeuzem, New kinetic models for the hepatitis C virus, Hepatology, vol.42, issue.4, pp.749-754, 2005.
DOI : 10.1002/hep.20882

A. Perelson and R. Ribeiro, Hepatitis B Virus Kinetics and Mathematical Modeling, Seminars in Liver Disease, vol.24, issue.1, pp.11-16, 2004.
DOI : 10.1055/s-2004-828673

R. Ribeiro, A. Lo, and A. Perelson, Dynamics of hepatitis B virus infection, Microbes and Infection, vol.4, issue.8, pp.829-835, 2002.
DOI : 10.1016/S1286-4579(02)01603-9

A. Perelson, Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed, Hepatology, vol.34, pp.1012-1020, 2001.

S. Lewin, T. Walters, and S. Locarnini, Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies, Antiviral Research, vol.55, issue.3
DOI : 10.1016/S0166-3542(02)00071-2

V. Sypsa, K. Mimidis, N. Tassopoulos, D. Chrysagis, T. Vassiliadis et al., A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative, Hepatology, vol.22, issue.1, pp.77-85, 2005.
DOI : 10.1002/hep.20738

F. Bonino, A multiphase model of the dynamics of HBV infection in HBeAgnegative patients during pegylated interferon-alpha2a, lamivudine and combination therapy, Antivir Ther, vol.11, pp.197-212, 2006.

J. Hoofnagle, E. Doo, T. Liang, R. Fleischer, and A. Lok, Management of hepatitis B: Summary of a clinical research workshop, Hepatology, vol.12, issue.4, pp.1056-1075, 2007.
DOI : 10.1002/hep.21627

A. Perelson, A. Kau, J. Vermehren, and C. Sarrazin, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Treatment predictors of a sustained virologic response in hepatitis B and C, Science J Hepatol, vol.28249, issue.33, pp.103-107634, 1998.

D. Madriaga, Assessment of the target-capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays, J Clin Microbiol, vol.42, pp.5199-5204, 2004.

M. Shuhart, Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily, J Viral Hepat, vol.11, pp.443-447, 2004.

D. Milich, F. Schodel, J. Hughes, J. Jones, and D. Peterson, The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype, J Virol, vol.71, pp.2192-2201, 1997.

M. Lindh, P. Horal, A. Dhillon, and G. Norkrans, Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B, Journal of Viral Hepatitis, vol.16, issue.4, pp.258-267, 2000.
DOI : 10.1016/S0168-8278(99)80247-5

L. Wolters, B. Hansen, H. Niesters, D. Dehertogh, and R. De-man, Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B, Journal of Hepatology, vol.37, issue.1, pp.137-144, 2002.
DOI : 10.1016/S0168-8278(02)00115-0

M. Tsiang, J. Rooney, J. Toole, and C. Gibbs, Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy, Hepatology, vol.19, issue.6, pp.1863-1869, 1999.
DOI : 10.1002/hep.510290626

E. Herrmann, Viral kinetics in patients with lamivudine-resistant hepatitis B during adefovir-lamivudine combination therapy, J Hepatol, vol.43, pp.217-224, 2005.